“…As detailed above, the complex array of altered pathways and ROS-related effects found in GSBS clearly must combine to block the pathological effects typically associated with an elevated Ang II. The myriad of oxidants, as well as changes in their levels, alongside the multiple pathways, organelles and organ systems involved found in GSBS patients, provides a rationale for why treatments aimed solely at “oxidants” have proven mostly unsuccessful on clinical grounds [ 43 , 44 ]. However, blocking multiple Ang II dependent signals, such as via blocking AT1R and ROCK activity, for example, does lead to the improvement of cardiovascular–renal remodeling, in part via a reduction of oxidative stress [ 18 , 45 , 46 ].…”